William Blair Equities Analysts Decrease Earnings Estimates for Privia Health Group, Inc. (NASDAQ:PRVA)

Privia Health Group, Inc. (NASDAQ:PRVA) – Equities researchers at William Blair lowered their Q2 2024 earnings estimates for shares of Privia Health Group in a research note issued on Thursday, August 8th. William Blair analyst R. Daniels now anticipates that the company will earn $0.03 per share for the quarter, down from their prior forecast of $0.05. The consensus estimate for Privia Health Group’s current full-year earnings is $0.19 per share.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Thursday, May 9th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. The business had revenue of $415.24 million for the quarter, compared to the consensus estimate of $435.07 million.

PRVA has been the subject of a number of other research reports. Stifel Nicolaus decreased their target price on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Robert W. Baird initiated coverage on shares of Privia Health Group in a report on Thursday, May 30th. They issued an “outperform” rating and a $23.00 price target for the company. Canaccord Genuity Group decreased their price target on shares of Privia Health Group from $37.00 to $26.00 and set a “buy” rating for the company in a report on Friday, May 10th. Baird R W raised shares of Privia Health Group to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Evercore ISI decreased their price target on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Two investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.54.

Privia Health Group Stock Down 1.4 %

NASDAQ:PRVA opened at $19.07 on Friday. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $27.40. The firm has a 50 day moving average of $18.15 and a 200 day moving average of $18.99. The stock has a market capitalization of $2.28 billion, a price-to-earnings ratio of 127.13, a PEG ratio of 3.18 and a beta of 0.78.

Insider Buying and Selling

In other news, Director Adam Boehler purchased 277,565 shares of the company’s stock in a transaction that occurred on Tuesday, May 21st. The shares were bought at an average price of $16.17 per share, for a total transaction of $4,488,226.05. Following the completion of the transaction, the director now owns 5,488,701 shares in the company, valued at $88,752,295.17. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Privia Health Group news, Director Thomas A. Mccarthy purchased 10,000 shares of the stock in a transaction that occurred on Thursday, May 23rd. The shares were purchased at an average cost of $16.37 per share, for a total transaction of $163,700.00. Following the completion of the transaction, the director now owns 52,611 shares of the company’s stock, valued at approximately $861,242.07. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Adam Boehler purchased 277,565 shares of the stock in a transaction that occurred on Tuesday, May 21st. The shares were acquired at an average price of $16.17 per share, for a total transaction of $4,488,226.05. Following the completion of the transaction, the director now directly owns 5,488,701 shares of the company’s stock, valued at approximately $88,752,295.17. The disclosure for this purchase can be found here. Insiders acquired a total of 293,235 shares of company stock valued at $4,745,481 over the last 90 days. Insiders own 14.20% of the company’s stock.

Hedge Funds Weigh In On Privia Health Group

Institutional investors and hedge funds have recently bought and sold shares of the business. Nisa Investment Advisors LLC boosted its position in Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after acquiring an additional 930 shares during the last quarter. Signaturefd LLC raised its stake in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after purchasing an additional 626 shares during the period. Park Place Capital Corp raised its stake in Privia Health Group by 115.4% during the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after purchasing an additional 1,335 shares during the period. Benjamin Edwards Inc. raised its stake in Privia Health Group by 44.9% during the fourth quarter. Benjamin Edwards Inc. now owns 3,239 shares of the company’s stock worth $75,000 after purchasing an additional 1,003 shares during the period. Finally, Covestor Ltd raised its stake in Privia Health Group by 25.5% during the first quarter. Covestor Ltd now owns 5,292 shares of the company’s stock worth $104,000 after purchasing an additional 1,076 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.